益气化瘀汤对冠心病介入术后患者气虚血瘀评分及终点事件影响临床分析  

Analysis Clinical of Effect of Yiqi Huayu Decoction on Qi Deficiency and Blood Stasis Score and Terminal event in Coronary Heart Disease Patients with Percutaneous Coronary Intervention

作　　者：黄国强[1] 缪灿铭[1] 李雪山[1] 

机构地区：[1]中山市中医院,广东中山528400

出　　处：《辽宁中医药大学学报》2017年第1期171-173,共3页Journal of Liaoning University of Traditional Chinese Medicine

基　　金：中山市科技计划立项重大项目(20113A003)

摘　　要：目的:观察探讨益气化瘀汤对冠心病介入术后患者临床疗效及价值分析。方法:选取我院2013年3月—2015年9月收纳的98例冠心病介入术后患者,按随机分配原则分为观察组和对照组,各49例,观察组冠心病介入术后患者,在对照组基础治疗上,加用益气化瘀汤治疗,对照组冠心病介入术后患者,采用常规西药治疗。以半年为1个疗程,治疗后随访半年。观察两组患者治疗前后气虚血瘀评分及终点事件发生情况。结果:观察组冠心病介入术后患者与对照组相比在治疗后各时间段气虚血瘀证候评分上有显著差异(P<0.05)。观察组冠心病介入术后患者在治疗后各时间段血瘀证评分与对照组相比,具有显著差异(P<0.05)。对照组冠心病介入术后患者终点事件发生率22.4%,观察组冠心病介入术后患者终点事件发生率6.1%,有统计学意义(P<0.05)。结论:益气化瘀汤对冠心病介入术后患者气虚血瘀评分及终点事件影响显著,明显改善气虚血瘀评分与减少终点事件发生率,从而缓解气虚血瘀证候的高危状态,具有扩张血管、改善微循环、活血化瘀的作用,诸药合用,共奏益气活血、通络化瘀之效,延长患者生存周期,提高生活质量,其临床选择优势较高。Objective：To observe and discuss the clinical effect and value of Yiqi Huayu Decoction in patients with percutaneous coronary intervention. Methods：Selected in our hospital in March 2013 and 2015 September containing 98 cases of coronary heart disease（CHD）in postoperative patients with PCI,divided into the observation group and the control group according to the principle of random assignment,49 cases in the observation group of coronary heart disease intervention in postoperative patients,based on the treatment of the control group and were given Yiqi Huayu Decoction in the treatment,control group of coronary heart disease patients after operation were treated by conventional Western medicine treatment. Six months as a course of treatment,followed up for half a year. To observe the two groups of patients before and after treatment of Qi deficiency and blood stasis score and the occurrence of terminal event. Results：Compared with the patients of the control group after treatment,patients of observation group were very different（P〈0.05）compared with the scores of Qi deficiency and blood stasis syndrome. Blood stasis of the observation group of patients with coronary heart disease after the treatment in each time period was difference compared with control group（P〈0.05）. Observation group of percutaneous coronary intervention postoperative patients with terminal event occurrence rate of 6.1%,control group coronary intervention postoperative patients with terminal event rate of 22.4%,observation group of terminal event rates were lower than control group（P〈0.05）. Conclusion：Yiqi Huayu Decoction on coronary heart disease intervention postoperative patients with Qi deficiency. Yiqi Huayu Decoction make improvement in Qi deficiency and blood stasis score and reduce the incidence of terminal event,and alleviate the risk state of Qi deficiency and blood stasis syndrome,make patients life longer and enhance patients life quality.

关 键 词：益气化瘀汤 冠心病 气虚血瘀 终点事件 

分 类 号：R541.4[医药卫生—心血管疾病]